October 25, 2021
Aducanumab and the Business of Alzheimer Disease; Implicit Light Sensitivity in Migraine
Neurology® PodcastAbout this episode
In the first part of the podcast, Dr. Jason Crowell discusses the business of Alzheimer disease and how to approach teaching patients about aducanumab with Dr. Jason Karlawish. In the second segment, Dr. Jennifer Bickel talks with Dr. Eric Kaiser about the contribution of melanopsin and cone signals to light-induced reflexive eye closure in migraine.